In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist

By Ozaki S.   Kawamoto H.   Itoh Y.   Miyaji M.   Azuma T.   Ichikawa D.   Nambu H.   Iguchi T.   Iwasawa Y.   Ohta H.  

European Journal of Pharmacology, Vol. 402, Iss. 1, 2000-08 ,pp. : 45-53

Elsevier

Access to resources Recommend Favorite

Pharmacological characterization of EK112, a new combined angiotensin II and thromboxane A 2 receptor antagonist

By Hwang T.-L.   Yeh Y.-A.   Chern J.-W.   Teng C.-M.  

General Pharmacology, Vol. 34, Iss. 1, 2000-01 ,pp. : 25-31

Elsevier

Access to resources Recommend Favorite

Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist

By Shibasaki M.   Fujimori A.   Takanashi M.   Kusayama T.   Tokioka T.   Satoh Y.   Okazaki T.   Uchida W.   Inagaki O.   Yanagisawa I.  

European Journal of Pharmacology, Vol. 335, Iss. 2, 1997-09 ,pp. : 167-173

Elsevier

Access to resources Recommend Favorite

Preclinical Pharmacology of Bilastine, a New Selective Histamine H1 Receptor Antagonist: Receptor Selectivity and in Vitro Antihistaminic Activity

By Corcóstegui Reyes   Labeaga Luis   Innerárity Ana   Berisa Agustin   Orjales Aurelio  

Drugs in R&D, Vol. 6, Iss. 6, 2005-01 ,pp. : 371-384

Adis International

Access to resources Recommend Favorite

In vitro pharmacology of an angiotensin AT 1 receptor antagonist with balanced affinity for AT 2 receptors

By Chang R.S.L.   Lotti V.J.   Tsing-Bau C.   O'Malley S.S.   Bendesky R.J.   Kling P.J.   Kivlighn S.D.   Siegl P.K.S.   Ondeyka D.   Greenlee W.J.   Mantlo N.B.  

European Journal of Pharmacology, Vol. 294, Iss. 2, 1995-12 ,pp. : 429-437

Elsevier

Access to resources Recommend Favorite